Matthew Patterson

Overview

Matthew Patterson received an average of $3M in total compensation, including $470K in salary, at Audentes Therapeutics from 2015 to 2018.

Source: SEC filings on April 26, 2019, April 27, 2018, and April 27, 2017.

Related executives

We found five more executives who work or worked at Audentes Therapeutics.

Natalie Holles

Audentes Therapeutics

Chief Operating Officer

Suyash Prasad

Audentes Therapeutics

Chief Medical Officer

John Gray

Audentes Therapeutics

Chief Technology Officer

Thomas Soloway

Audentes Therapeutics

Chief Financial Officer

Tom Soloway

Audentes Therapeutics

Chief Financial Officer

News

You may also like